TENAHIR-M 500 Tablets
TENAHIR-M 500 is a highly effective, dual-action prescription oral hypoglycemic combination designed for the comprehensive management of Type 2 Diabetes Mellitus. By combining a DPP-4 inhibitor with a biguanide in an extended-release formulation, it provides synergistic glycemic control, helps stabilize blood sugar spikes after meals, and maintains consistent glucose levels throughout the day.
Key Features & Benefits
-
Dual-Mechanism Blood Sugar Control: Combines two distinct anti-diabetic agents that work through complementary pathways to lower hemoglobin A1c (HbA1c) levels more effectively than monotherapy.
-
Extended-Release (ER) Technology: Formulated to release Metformin gradually into the system, ensuring stable, 24-hour glucose management while significantly minimizing common gastrointestinal side effects.
-
Smart Insulin Regulation: Enhances the body’s natural ability to produce insulin in response to meals while suppressing unnecessary glucose production by the liver.
-
Bulk Clinical Packaging: Supplied in a standard clinical $10 \times 10$ tablets pack, making it ideal for continuous, long-term chronic therapy management.